theory clinical_30_7
imports Main

begin

typedecl entity
typedecl event

consts
  Mutation :: "entity ⇒ bool"
  Activating :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cell :: "entity ⇒ bool"
  βCatenin :: "entity ⇒ bool"
  Promote :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Reduce :: "event ⇒ bool"
  Stop :: "event ⇒ bool"
  Cause :: "event ⇒ entity ⇒ bool"
  CrucialStep :: "event ⇒ bool"
  Treat :: "event ⇒ bool"
  Address :: "event ⇒ bool"
  Directly :: "event ⇒ bool"
  Make :: "event ⇒ bool"
  EffectiveTreatment :: "event ⇒ bool"
  Effective :: "event ⇒ bool"
  Treatment :: "event ⇒ bool"
  Ability :: "event ⇒ bool"
  Target :: "event ⇒ bool"
  Pathway :: "entity ⇒ bool"
  Lead :: "event ⇒ bool"
  PatientEntity :: "entity ⇒ bool"  (* Renamed to avoid conflict *)
  In :: "entity ⇒ entity ⇒ bool"
  Enhance :: "event ⇒ bool"
  ResponsibleFor :: "event ⇒ entity ⇒ bool"

(* Explanation 1: Activating mutations of CTNNB1 promote the proliferation of cells via β-catenin *)
axiomatization where
  explanation_1: "∃x y z e. Mutation x ∧ Activating x ∧ CTNNB1 x ∧ Proliferation y ∧ Cell z ∧ βCatenin z ∧ Promote e ∧ Agent e x ∧ Patient e y ∧ Via e z"

(* Explanation 2: Inhibiting β-catenin can reduce or stop the proliferation of cells caused by activating mutations of CTNNB1, and this reduction or cessation is a crucial step in treating these mutations *)
axiomatization where
  explanation_2: "∃x y z e1 e2 e3. Inhibit e1 ∧ βCatenin x ∧ Proliferation y ∧ Cell z ∧ Mutation z ∧ Activating z ∧ CTNNB1 z ∧ Reduce e2 ∧ Stop e3 ∧ Agent e2 x ∧ Agent e3 x ∧ Patient e2 y ∧ Patient e3 y ∧ Cause e2 z ∧ Cause e3 z ∧ CrucialStep e2 ∧ CrucialStep e3 ∧ Treat e2 ∧ Treat e3 ∧ Patient e2 z ∧ Patient e3 z"

(* Explanation 3: Reducing or stopping the proliferation of cells through inhibiting β-catenin directly addresses the underlying cause of cell proliferation, making it an effective treatment for patients with activating CTNNB1 mutations *)
axiomatization where
  explanation_3: "∃x y z w e1 e2 e3 e4. Reduce e1 ∧ Stop e2 ∧ Proliferation y ∧ Cell z ∧ Inhibit e3 ∧ βCatenin x ∧ Cause e4 w ∧ Address e4 ∧ Agent e1 x ∧ Agent e2 x ∧ Agent e3 x ∧ Agent e4 x ∧ Patient e1 y ∧ Patient e2 y ∧ Patient e4 w ∧ Directly e4 ∧ Make e4 ∧ EffectiveTreatment e4 ∧ Patient e4 z ∧ Mutation z ∧ Activating z ∧ CTNNB1 z"

(* Explanation 4: The effectiveness of inhibiting β-catenin as a treatment is due to its ability to target the specific pathway that leads to cell proliferation in patients with activating CTNNB1 mutations *)
axiomatization where
  explanation_4: "∃x y z w e1 e2 e3. Effective e1 ∧ Inhibit e2 ∧ βCatenin x ∧ Treatment e1 ∧ Ability e3 ∧ Target e3 ∧ Pathway y ∧ Lead e3 ∧ Proliferation z ∧ Cell z ∧ PatientEntity w ∧ Mutation w ∧ Activating w ∧ CTNNB1 w ∧ Agent e2 x ∧ Agent e3 x ∧ Patient e3 y ∧ Patient e3 z ∧ In w z"

(* Explanation 5: Inhibiting β-catenin not only reduces cell proliferation but also enhances the effectiveness of treatment for patients with activating CTNNB1 mutations by directly targeting the pathway responsible for cell proliferation *)
axiomatization where
  explanation_5: "∃x y z w e1 e2 e3 e4. Inhibit e1 ∧ βCatenin x ∧ Proliferation y ∧ Cell y ∧ Reduce e2 ∧ Enhance e3 ∧ EffectiveTreatment e3 ∧ PatientEntity z ∧ Mutation z ∧ Activating z ∧ CTNNB1 z ∧ Pathway w ∧ Target e4 ∧ ResponsibleFor e4 y ∧ Directly e4 ∧ Agent e1 x ∧ Agent e2 x ∧ Agent e3 x ∧ Agent e4 x ∧ Patient e2 y ∧ Patient e3 z ∧ Patient e4 w"

theorem hypothesis:
  assumes asm: "βCatenin x ∧ PatientEntity y ∧ Mutation y ∧ Activating y ∧ CTNNB1 y"
  (* Hypothesis: Inhibiting β-catenin may be effective in treating patients with activating CTTNB1 mutations *)
  shows "∃x y e1 e2. Inhibit e1 ∧ βCatenin x ∧ PatientEntity y ∧ Mutation y ∧ Activating y ∧ CTNNB1 y ∧ Agent e1 x ∧ Effective e2 ∧ Treat e2 ∧ Patient e2 y"
proof -
  (* From the premise, we have known information about β-catenin, patient entity, mutation, activating, and CTNNB1. *)
  from asm have "βCatenin x ∧ PatientEntity y ∧ Mutation y ∧ Activating y ∧ CTNNB1 y" by blast
  (* There is a logical relation Implies(D, F), Implies(inhibiting β-catenin, treatment for activating CTNNB1 mutations) *)
  (* We need to show that inhibiting β-catenin is effective in treating patients with activating CTNNB1 mutations. *)
  (* From explanation 2, we know that inhibiting β-catenin can reduce or stop the proliferation of cells caused by activating mutations of CTNNB1, and this reduction or cessation is a crucial step in treating these mutations. *)
  (* From explanation 5, inhibiting β-catenin not only reduces cell proliferation but also enhances the effectiveness of treatment for patients with activating CTNNB1 mutations. *)
  (* Therefore, inhibiting β-catenin is effective in treating patients with activating CTNNB1 mutations. *)
  then have "∃e1 e2. Inhibit e1 ∧ βCatenin x ∧ Agent e1 x ∧ Effective e2 ∧ Treat e2 ∧ Patient e2 y" sledgehammer
  then show ?thesis <ATP>
qed

end
